FindTrial
Sign In

Efficacy and safety of pregabalin for the treatment of postoperative pain in ERAS total knee arthroplasty: A Prospective Randomized Controlled Trial

Efficacy and safety of pregabalin for the treatment of postoperative pain in ERAS total knee arthroplasty: A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008834
Enrollment
Unknown
Registered
2016-07-13
Start date
2016-07-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Group A:traditional pain managment
Group B:Conbination of traditional pain managment and oral pregabalin

Sponsors

West China Hospital, Sichuan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients, aged 18 years and older, who were scheduled for a primary TKA because of the end-staged osteoarthritis

Exclusion criteria

Exclusion criteria: Exclusion criteria included revisions, bilateral procedures, previous knee surgery history, flexion deformity=30 degree, varus/valgus deformity=30 degree, chronic gabapentin or pregabalin use (regular use for longer than 3 months) and contraindications for the use of pregabalin

Design outcomes

Primary

MeasureTime frame
VAS score;opioid consumption;complications;—

Secondary

MeasureTime frame
the length of hospital stays;patient satisfaction;CRP;—

Countries

China

Contacts

Public ContactFuxing Pei

West China Hospital, SiChuan University

peifuxing1952@163.com+86 13551068719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026